XORTX Therapeutics Inc (XRTX) — Defensive Interval Ratio
XORTX Therapeutics Inc (XRTX) has a Defensive Interval Ratio of 10 days as of September 2025. Defensive assets of CA$22.09K (cash CA$-, short-term investments CA$-, receivables CA$22.09K) cover 10 days of daily cash needs of CA$2.29K/day. See XRTX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
XORTX Therapeutics Inc Defensive Interval Ratio (2017–2024)
This chart shows how XORTX Therapeutics Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 10 days, meaning defensive assets of CA$22.09K can fund 10 days of operations without new revenue. See XRTX net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for XORTX Therapeutics Inc (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for XORTX Therapeutics Inc from 2017 to 2024, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see XORTX Therapeutics Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (CAD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 8 days | CA$17.64K | CA$2.08K/day | CA$- | CA$- | ▼ -18 days |
| 2023 | 27 days | CA$60.71K | CA$2.26K/day | CA$- | CA$- | ▲ +12 days |
| 2022 | 15 days | CA$81.75K | CA$5.62K/day | CA$- | CA$- | ▼ -7 days |
| 2021 | 21 days | CA$40.65K | CA$1.92K/day | CA$- | CA$- | ▲ +17 days |
| 2020 | 4 days | CA$11.25K | CA$2.83K/day | CA$- | CA$- | ▲ +1 days |
| 2019 | 3 days | CA$8.97K | CA$3.56K/day | CA$- | CA$- | ▼ -10 days |
| 2018 | 12 days | CA$30.26K | CA$2.47K/day | CA$- | CA$- | ▲ +12 days |
| 2017 | 1 days | CA$1.61K | CA$3.04K/day | CA$- | CA$- | — |